Gilead Elated as the FDA OKs New Blockbuster HIV Pill Biktarvy Post author:Sam Post published:February 7, 2018 Post category:BioPharma The FDA approved Gilead’s triple combination treatment for HIV, Biktarvy. Source: BioSpace You Might Also Like <b>MVRx</b> To Present Outcomes Of Global Clinical Trials For ARTO System At Europcr 2017 ??? May 16-17 May 11, 2017 Karolinska Development AB ??? Interim Report (January-June 2017) ??? Invitation To Conference Call And Webcast August 23, 2017 Jazz Pharma Announces Offering Of $500 Million Of 1.50% Exchangeable Senior Notes Due 2024 August 17, 2017
<b>MVRx</b> To Present Outcomes Of Global Clinical Trials For ARTO System At Europcr 2017 ??? May 16-17 May 11, 2017
Karolinska Development AB ??? Interim Report (January-June 2017) ??? Invitation To Conference Call And Webcast August 23, 2017
Jazz Pharma Announces Offering Of $500 Million Of 1.50% Exchangeable Senior Notes Due 2024 August 17, 2017
